$COSM: When the CEO Buys, I Pay Attention!

If you’ve been following Cosmos Health ($COSM), you know the narrative has always been about one thing: Grigorios Siokas (CEO) putting his money where his mouth is. Here is the breakdown of why this is hitting my radar for a potential reversal play. 1. The "CEO Loading" Thesis: CEO Grigorios Siokas is not just "buying the dip"; he is systematically converting company debt into equity. This is a massive vote of confidence because he is choosing to own shares at current prices rather than holding a senior position as a debt holder. Recent January 2026 "Loads": • Jan 14: Bought 493,495 shares at $0.44 ($220,000 value). • Jan 12: Bought 113,185 shares at $0.50. • Jan 08: Bought 156,190 shares at $0.51. • Jan 07: Bought 124,880 shares at $0.52. • Jan 06: Bought 133,953 shares at $0.53. In the last 6 months, Siokas has made 12 separate purchases totaling over 1.57 million shares. He now directly owns over 7.7 million shares. He hasn't sold a single share during this entire period. 2. Strategic Catalysts: Beyond the buying, the company is making moves to modernize its balance sheet: • $300M Treasury Management: Recently partnered with Prime Ledger LLC to digitally transform financial operations and manage a $300M treasury facility. • Product Expansion: Announced a 5-year manufacturing agreement for PathMuscle (muscle relaxant/pain reliever), with projected volumes exceeding 1.2M units. • Path to Profitability: Analysts (via InvestingPro) are projecting $COSM to turn profitable this fiscal year. Final Thoughts: When a CEO is buying nearly half a million shares in a single day (Jan 14) at $0.44, and the stock is currently sitting around $0.54, he's effectively setting a "floor." We are seeing high relative volume lately, and if this breaks past the $0.65 resistance, the gap to $1.00 (compliance target) is the primary goal. Not financial advice. Penny stocks are highly volatile. Do your own due diligence.